Ind-Swift Laboratories Ltd. (INDSWFTLA) 52 Week High Streak: Second Straight Session Near Peak

Ind-Swift Laboratories Ltd. 52 Week High Streak is now in its second straight session, with the stock trading near its 52-week high after a 2.89% move across the streak. The latest peak stood at Rs 417.70, while the current price was Rs 416.25 as of 29 September 2026 at 9:23 AM IST. The latest Univest figures confirm the repeated-near-high pattern, but they do not establish a company-specific catalyst for the continued move.

The previous close was Rs 408.30, the day opened at Rs 400.15 and the low was also Rs 400.15. The market capitalisation stood at Rs 3,518.03 crore. For readers tracking Ind-Swift Laboratories Ltd. Share Price, the key point is that a repeated high pattern carries a different signal from a one-day move because it shows persistence near the yearly peak, not just a single intraday visit.

Ind-Swift Laboratories Ltd. 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 416.25
Previous Close	Rs 408.3
Today's Move	+Rs 7.95 (+1.95%)
Open	Rs 400.15
High	Rs 417.7
Low	Rs 400.15
Market Capitalisation	Rs 3,518.03 crore

Ind-Swift Laboratories Ltd. (INDSWFTLA) traded at Rs 416.25 versus the previous close of Rs 408.3, a rise of 1.95%. The stock opened at Rs 400.15, reached a high of Rs 417.7 and touched a low of Rs 400.15.

Ind-Swift Laboratories Ltd. Share Price Today showed a measured move higher from the previous close, with the stock at Rs 416.25 versus Rs 408.30 previously. That is a gain of Rs 7.95 or 1.95% in the latest session, and it kept Ind-Swift Laboratories Ltd. 52 Week High Streak intact for a second straight session. The stock opened at Rs 400.15 and touched a high of Rs 417.70, leaving the latest price close to the top of the day’s range.

This matters because the stock is not only near its 52-week high once; it has now stayed in that zone across consecutive sessions. The current market capitalisation of Rs 3,518.03 crore places the company in a clearly defined mid-sized bracket by value, and the repeated near-high pattern remains the main market news today. Ind-Swift Laboratories Ltd. Stock News around this move is therefore best read as a streak story first, not a single-session breakout story.

What the Repeated 52-Week Highs Show

Ind-Swift Laboratories Ltd. 52 Week High Streak indicates that the stock has stayed within 2% of its one-year peak for a second straight session, with a cumulative move of 2.89% across the streak. The latest high of Rs 417.70 is the current 52-week high, and the latest price action shows that the stock remains close to that level rather than far below it.

What the Repeated 52-Week Highs Show is not a question of certainty about the cause. The latest Univest data confirms the price pattern, but it does not identify a company-specific reason for the continued trade near the peak. For readers following Stocks Hitting 52 Week Highs, the useful takeaway is that this is a persistent near-high setup, not a one-off tick above a prior level. Ind-Swift Laboratories Ltd. New One Year High Again is therefore a fair descriptive phrase, but only in the sense of repeated proximity, not a claim of an all-time record.

Ind-Swift Laboratories Ltd. Share Price Update also matters in context because the streak is happening with a day range that stayed contained around the current level. In practical terms, the stock has held its position near the yearly high across back-to-back sessions, and that is what separates a consecutive 52-week high pattern from ordinary intraday noise.

Ind-Swift Laboratories Ltd. (INDSWFTLA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 3,518.03 crore
P/E Ratio	61.94x
P/B Ratio	2.52x
ROE	3.47%
ROCE	4%
EPS	Rs 6.59
Book Value Per Share	Rs 161.89
Dividend Yield	0%

Ind-Swift Laboratories Ltd. (INDSWFTLA) fundamental metrics show P/E 61.94x, P/B 2.52x, ROE 3.47%, ROCE 4%. These figures provide context only and are not a buy or sell signal.

Ind-Swift Laboratories Ltd. has a market capitalisation of Rs 3518.03 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 61.94x, P/B at 2.52x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 3.47% and ROCE of 4%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.59, book value per share of Rs 161.89, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.91x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	61.94x
Benchmark Median P/E	27.91x
Benchmark Average P/E	41.51x
Benchmark P/E Range	0x to 707.31x
Company P/B Ratio	2.52x
Benchmark Median P/B	2.88x
Company ROE	3.47%
Benchmark Median ROE	11.74%
Company ROCE	4%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 3,518.03 crore
Benchmark Median Market Cap	Rs 782.41 crore

Ind-Swift Laboratories Ltd. (INDSWFTLA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Ind-Swift Laboratories Ltd. (INDSWFTLA) has a P/E ratio of 61.94x, which is above the benchmark median of 27.91x, a difference of +121.93%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Ind-Swift Laboratories Ltd. (INDSWFTLA) has a ROE of 3.47%, which is below the benchmark median of 11.74%, a difference of -70.44%. Ind-Swift Laboratories Ltd. (INDSWFTLA) has a ROCE of 4%, which is below the benchmark median of 13.63%, a difference of -70.65%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Solara Active Pharma Sciences Ltd.	SOLARA	3,556.79	0	2.8	-0.63	4.61
Advanced Enzyme Technologies Ltd.	ADVENZYMES	3,263.54	19.16	1.91	11.43	15.27
Kwality Pharmaceuticals Ltd.	KPL	3,809.57	45.84	10.42	22.67	24.01
Unichem Laboratories Ltd.	UNICHEMLAB	3,873.72	12.41	1.37	9.81	10.68
Aarti Drugs Ltd.	AARTIDRUGS	3,922.33	20.48	2.45	13.36	12.04

Ind-Swift Laboratories Ltd. (INDSWFTLA) has a P/E ratio of 61.94x compared with the displayed peer median of 19.16x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 3.47% compares with a peer median of 11.43% across the companies shown in the table. ROCE stood at 4% versus the displayed peer median of 12.04%, providing a capital-efficiency comparison. Ind-Swift Laboratories Ltd. (INDSWFTLA) has a market capitalisation of Rs 3,518.03 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Ind-Swift Laboratories Ltd.

• Ind-Swift Laboratories Ltd. 52 Week High Streak has continued for a second straight session, keeping the stock near its one-year peak.
• The cumulative move across the streak is 2.89%, which gives a clearer view than a single-day change.
• The current price of Rs 416.25 remains close to the latest high of Rs 417.70.
• The company’s P/E of 61.94 is above the industry median, so valuation remains an important check.
• The healthcare and pharmaceuticals backdrop keeps Ind-Swift Laboratories Ltd. Share Price in focus among 52 Week High Stocks.

About Ind-Swift Laboratories Ltd.

Ind-Swift Laboratories Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company’s latest market capitalisation was Rs 3,518.03 crore, with an EPS of Rs 6.59 and book value of Rs 161.89. Dividend yield was 0%.

Ind-Swift Laboratories Ltd. Stock Analysis today is shaped by the combination of a repeated near-52-week-high pattern and a valuation that sits above the industry median on earnings. For readers tracking Ind-Swift Laboratories Ltd. Share Price, the company remains in the spotlight because the price action and the reported fundamentals are being watched together, not separately.

Image ALT: Ind-Swift Laboratories Ltd. 52 Week High Streak analysis showing repeated near-yearly-high trading.

Conclusion: Ind-Swift Laboratories Ltd. 52 Week High Streak is the main market cue today, and the stock’s repeated trade near its yearly peak keeps the move in focus for investors following the share price, valuation and sector context.

Frequently Asked Questions

What does Ind-Swift Laboratories Ltd. 52 Week High Streak mean?

Ans. It means the stock has traded within 2% of its 52-week high for consecutive sessions. In this case, the streak has lasted for a second straight session, which keeps the yearly-high pattern in focus for readers tracking the share price.

How many sessions has Ind-Swift Laboratories Ltd. stayed near its high?

Ans. The stock has stayed near its 52-week high for two consecutive sessions. The streak label provided for this event is second straight session, and the cumulative move across that period is 2.89%.

What is the current price of Ind-Swift Laboratories Ltd.?

Ans. The latest price was Rs 416.25 as of 29 September 2026 at 9:23 AM IST. That level kept the stock very close to its latest 52-week high.

Did Ind-Swift Laboratories Ltd. set a new 52-week high today?

Ans. The latest figures show the stock trading near its 52-week high, but they do not support saying it set a new high today. The correct reading is that it remained close to the peak across back-to-back sessions.

What does the repeated high pattern show?

Ans. It shows persistence near the yearly peak across consecutive sessions. The figures confirm the price pattern, but they do not establish a company-specific catalyst for why the stock kept trading in that zone.

How does Ind-Swift Laboratories Ltd. compare with peers on valuation?

Ans. The company’s P/E of 61.94 is above the industry median of 27.91. That makes it richer than several peer names in the same industry comparison set, even though its P/B is below the industry median.

What do the fundamentals show for Ind-Swift Laboratories Ltd.?

Ans. The latest figures show ROE of 3.47%, ROCE of 4%, P/B of 2.52, EPS of Rs 6.59 and book value of Rs 161.89. These numbers give a mixed fundamental picture alongside the repeated high pattern.

What should investors monitor next?

Ans. Investors can watch whether the stock keeps trading near the same yearly peak while also tracking future financial results and valuation context. The repeated-high pattern is important, but it should be read together with the company’s operating metrics and peer comparison.

Track Ind-Swift Laboratories Ltd. (INDSWFTLA) Share Price on Univest

Use Ind-Swift Laboratories Ltd. (INDSWFTLA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.